The heparan sulfate editing enzyme Sulf1 plays a novel role in zebrafish VegfA mediated arterial venous identity

Bushra Gorsi, Feng Liu, Xing Ma, Timothy J A Chico, Ashok Shrinivasan, Ken Kramer, Esther Bridges, Rui Monteiro, Adrian L. Harris, Roger Patient, Sally E. Stringer

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Arterial and venous specification is critical for establishing and maintaining a functioning vascular system, and defects in key arteriovenous signaling pathways including VEGF (vascular endothelial growth factor) lead to congenital arteriopathies. The activities of VEGF, are in part controlled by heparan sulfate (HS) proteoglycans, significant components of the endothelial glycocalyx. The level of 6-O sulfation on HS polysaccharide chains, that mediate the interaction between HS and VEGFA, is edited at the cell surface by the enzyme SULF1. We investigated the role of sulf1 in vascular development. In zebrafish sulf1 is expressed in the head and tail vasculature, corresponding spatially and temporally with vascular development. Targeted knockdown of sulf1 by antisense morpholinos resulted in severe vascular patterning and maturation defects. 93 % of sulf1 morphants show dysmorphogenesis in arterial development leading to occlusion of the distal aorta and lack of axial and cranial circulation. Co-injection of vegfa 165 mRNA rescued circulatory defects. While the genes affecting haematopoiesis are unchanged, expression of several arterial markers downstream of VegfA signalling such as notch and ephrinB2 are severely reduced in the dorsal aorta, with a concomitant increase in expression of the venous markers flt4 in the dorsal aorta of the morphants. Furthermore, in vitro, lack of SULF1 expression downregulates VEGFA-mediated arterial marker expression, confirming that Sulf1 mediates arterial specification by regulating VegfA165 activity. This study provides the first in vivo evidence for the integral role of the endothelial glycocalyx in specifying arterial-venous identity, vascular patterning and arterial integrity, and will help to better understand congenital arteriopathies.

Original languageEnglish
Pages (from-to)77-91
Number of pages15
JournalAngiogenesis
Volume17
Issue number1
DOIs
StatePublished - Jan 2014
Externally publishedYes

Fingerprint

Heparitin Sulfate
Zebrafish
Blood Vessels
Defects
Vascular Endothelial Growth Factor A
Enzymes
Aorta
Glycocalyx
Specifications
Morpholinos
Heparan Sulfate Proteoglycans
Polysaccharides
Genes
Hematopoiesis
Messenger RNA
Tail
Down-Regulation
Injections

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Physiology
  • Clinical Biochemistry

Cite this

The heparan sulfate editing enzyme Sulf1 plays a novel role in zebrafish VegfA mediated arterial venous identity. / Gorsi, Bushra; Liu, Feng; Ma, Xing; Chico, Timothy J A; Shrinivasan, Ashok; Kramer, Ken; Bridges, Esther; Monteiro, Rui; Harris, Adrian L.; Patient, Roger; Stringer, Sally E.

In: Angiogenesis, Vol. 17, No. 1, 01.2014, p. 77-91.

Research output: Contribution to journalArticle

Gorsi, B, Liu, F, Ma, X, Chico, TJA, Shrinivasan, A, Kramer, K, Bridges, E, Monteiro, R, Harris, AL, Patient, R & Stringer, SE 2014, 'The heparan sulfate editing enzyme Sulf1 plays a novel role in zebrafish VegfA mediated arterial venous identity', Angiogenesis, vol. 17, no. 1, pp. 77-91. https://doi.org/10.1007/s10456-013-9379-0
Gorsi, Bushra ; Liu, Feng ; Ma, Xing ; Chico, Timothy J A ; Shrinivasan, Ashok ; Kramer, Ken ; Bridges, Esther ; Monteiro, Rui ; Harris, Adrian L. ; Patient, Roger ; Stringer, Sally E. / The heparan sulfate editing enzyme Sulf1 plays a novel role in zebrafish VegfA mediated arterial venous identity. In: Angiogenesis. 2014 ; Vol. 17, No. 1. pp. 77-91.
@article{4c646510cadc4887b5d5e2a0d675b685,
title = "The heparan sulfate editing enzyme Sulf1 plays a novel role in zebrafish VegfA mediated arterial venous identity",
abstract = "Arterial and venous specification is critical for establishing and maintaining a functioning vascular system, and defects in key arteriovenous signaling pathways including VEGF (vascular endothelial growth factor) lead to congenital arteriopathies. The activities of VEGF, are in part controlled by heparan sulfate (HS) proteoglycans, significant components of the endothelial glycocalyx. The level of 6-O sulfation on HS polysaccharide chains, that mediate the interaction between HS and VEGFA, is edited at the cell surface by the enzyme SULF1. We investigated the role of sulf1 in vascular development. In zebrafish sulf1 is expressed in the head and tail vasculature, corresponding spatially and temporally with vascular development. Targeted knockdown of sulf1 by antisense morpholinos resulted in severe vascular patterning and maturation defects. 93 {\%} of sulf1 morphants show dysmorphogenesis in arterial development leading to occlusion of the distal aorta and lack of axial and cranial circulation. Co-injection of vegfa 165 mRNA rescued circulatory defects. While the genes affecting haematopoiesis are unchanged, expression of several arterial markers downstream of VegfA signalling such as notch and ephrinB2 are severely reduced in the dorsal aorta, with a concomitant increase in expression of the venous markers flt4 in the dorsal aorta of the morphants. Furthermore, in vitro, lack of SULF1 expression downregulates VEGFA-mediated arterial marker expression, confirming that Sulf1 mediates arterial specification by regulating VegfA165 activity. This study provides the first in vivo evidence for the integral role of the endothelial glycocalyx in specifying arterial-venous identity, vascular patterning and arterial integrity, and will help to better understand congenital arteriopathies.",
author = "Bushra Gorsi and Feng Liu and Xing Ma and Chico, {Timothy J A} and Ashok Shrinivasan and Ken Kramer and Esther Bridges and Rui Monteiro and Harris, {Adrian L.} and Roger Patient and Stringer, {Sally E.}",
year = "2014",
month = "1",
doi = "10.1007/s10456-013-9379-0",
language = "English",
volume = "17",
pages = "77--91",
journal = "Angiogenesis",
issn = "0969-6970",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - The heparan sulfate editing enzyme Sulf1 plays a novel role in zebrafish VegfA mediated arterial venous identity

AU - Gorsi, Bushra

AU - Liu, Feng

AU - Ma, Xing

AU - Chico, Timothy J A

AU - Shrinivasan, Ashok

AU - Kramer, Ken

AU - Bridges, Esther

AU - Monteiro, Rui

AU - Harris, Adrian L.

AU - Patient, Roger

AU - Stringer, Sally E.

PY - 2014/1

Y1 - 2014/1

N2 - Arterial and venous specification is critical for establishing and maintaining a functioning vascular system, and defects in key arteriovenous signaling pathways including VEGF (vascular endothelial growth factor) lead to congenital arteriopathies. The activities of VEGF, are in part controlled by heparan sulfate (HS) proteoglycans, significant components of the endothelial glycocalyx. The level of 6-O sulfation on HS polysaccharide chains, that mediate the interaction between HS and VEGFA, is edited at the cell surface by the enzyme SULF1. We investigated the role of sulf1 in vascular development. In zebrafish sulf1 is expressed in the head and tail vasculature, corresponding spatially and temporally with vascular development. Targeted knockdown of sulf1 by antisense morpholinos resulted in severe vascular patterning and maturation defects. 93 % of sulf1 morphants show dysmorphogenesis in arterial development leading to occlusion of the distal aorta and lack of axial and cranial circulation. Co-injection of vegfa 165 mRNA rescued circulatory defects. While the genes affecting haematopoiesis are unchanged, expression of several arterial markers downstream of VegfA signalling such as notch and ephrinB2 are severely reduced in the dorsal aorta, with a concomitant increase in expression of the venous markers flt4 in the dorsal aorta of the morphants. Furthermore, in vitro, lack of SULF1 expression downregulates VEGFA-mediated arterial marker expression, confirming that Sulf1 mediates arterial specification by regulating VegfA165 activity. This study provides the first in vivo evidence for the integral role of the endothelial glycocalyx in specifying arterial-venous identity, vascular patterning and arterial integrity, and will help to better understand congenital arteriopathies.

AB - Arterial and venous specification is critical for establishing and maintaining a functioning vascular system, and defects in key arteriovenous signaling pathways including VEGF (vascular endothelial growth factor) lead to congenital arteriopathies. The activities of VEGF, are in part controlled by heparan sulfate (HS) proteoglycans, significant components of the endothelial glycocalyx. The level of 6-O sulfation on HS polysaccharide chains, that mediate the interaction between HS and VEGFA, is edited at the cell surface by the enzyme SULF1. We investigated the role of sulf1 in vascular development. In zebrafish sulf1 is expressed in the head and tail vasculature, corresponding spatially and temporally with vascular development. Targeted knockdown of sulf1 by antisense morpholinos resulted in severe vascular patterning and maturation defects. 93 % of sulf1 morphants show dysmorphogenesis in arterial development leading to occlusion of the distal aorta and lack of axial and cranial circulation. Co-injection of vegfa 165 mRNA rescued circulatory defects. While the genes affecting haematopoiesis are unchanged, expression of several arterial markers downstream of VegfA signalling such as notch and ephrinB2 are severely reduced in the dorsal aorta, with a concomitant increase in expression of the venous markers flt4 in the dorsal aorta of the morphants. Furthermore, in vitro, lack of SULF1 expression downregulates VEGFA-mediated arterial marker expression, confirming that Sulf1 mediates arterial specification by regulating VegfA165 activity. This study provides the first in vivo evidence for the integral role of the endothelial glycocalyx in specifying arterial-venous identity, vascular patterning and arterial integrity, and will help to better understand congenital arteriopathies.

UR - http://www.scopus.com/inward/record.url?scp=84892781122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892781122&partnerID=8YFLogxK

U2 - 10.1007/s10456-013-9379-0

DO - 10.1007/s10456-013-9379-0

M3 - Article

C2 - 23959107

AN - SCOPUS:84892781122

VL - 17

SP - 77

EP - 91

JO - Angiogenesis

JF - Angiogenesis

SN - 0969-6970

IS - 1

ER -